Loading market intelligence…
Aspen Bio is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Aspen Bio is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Position by illustrative valuation within the tracked sector.
Explore sector ↗| 2026-03-10 | Series A | $44M | $5.1B | Peninsula Growth | Frontier Works, Marin Family Partners | Demo · Unverified |
| 2025-05-12 | Series A | $14M | Not disclosed | Peninsula Growth | Frontier Works, Marin Family Partners | Demo · Unverified |
| 2024-05-08 | Seed | $3M | Not disclosed | Peninsula Growth | Frontier Works, Marin Family Partners | Demo · Unverified |
Illustrative founding year
| Helix Discovery | Biotech | $36.1B | $483M | Growth |
| Cellular Atlas | Biotech | $16.3B | $204M | Series C+ |
| Cedar Bio | Biotech | $10.5B | $129M | Series C+ |
| Oak Bio | Biotech | $7.8B | $95M | Series B |
All metrics on this profile originate in the SVI illustrative dataset. Published and retrieved Sep 18, 2026. Last verified: not verified. No original external publication exists for synthetic records.
Demo dataset · Sep 18, 2026